Notice of Extraordinary General Meeting, proposed company dissolution and delisting Ronny SkuggedalFebruary 23, 2026
PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process Ronny SkuggedalJanuary 29, 2026
PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options Ronny SkuggedalJanuary 8, 2026
